1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8975256
APP PUB NO 20130303537A1
SERIAL NO

13937447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A 1,2,3,4-tetrahydroquinoxaline compound represented by the following formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANTEN PHARMACEUTICAL CO LTD9-19 SHIMOSHINJO 3-CHOME HIGASHIYODOGAWA-KU OSAKA-SHI OSAKA 533-8651

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kato, Masatomo Ikoma, JP 27 100
Kawashima, Kenji Ikoma, JP 47 460
Kobayashi, Sachiko Ikoma, JP 62 489
Matsuda, Mamoru Ikoma, JP 17 101
Mori, Toshiyuki Ikoma, JP 55 417
Nagatsuka, Masato Ikoma, JP 14 81
Takai, Miwa Ikoma, JP 17 108
Yamamoto, Minoru Ikoma, JP 162 1468

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00